全球預填充式注射器市場:2020年∼2024年

全球預填充式注射器的市場規模在2020年∼2024年間，預測將成長到42億3,000萬美元，在預測期間內預計將以13％的年複合成長率增長。市場成長的主要因素有製藥企業的利用增加與有利於市場的法規及指南。

本報告提供預填充式注射器市場調查，提供市場概要，市場成長要素及阻礙因素分析，各用途·不同材料·各終端用戶·各地區的市場規模的變化與預測，供應商分析，市場機會等全面性資訊。

目錄

摘要整理

市場形勢

市場規模

• 市場定義
• 市場區隔分析
• 2019年的市場規模
• 市場預測:2019年-2024年的預測

波特的五力分析

不同材料市場區隔

• 市場·市場區隔
• 不同材料比較
• 玻璃製預填充式注射器-市場規模與預測(2019年-2024年)
• 塑膠製預填充式注射器-市場規模與預測(2019年-2024年)
• 不同材料市場機會

各用途市場市場區隔

• 胰島素注射器
• 疫苗注射器
• 抗凝固劑注射器
• 其他

各終端用戶市場區隔

• 醫院·診療所
• 家庭醫療保健

客戶形勢

各地區形勢

• 各地區市場區隔
• 各地區比較
• 歐洲-市場規模與預測(2019年-2024年)
• 北美 -市場規模與預測(2019年-2024年)
• 亞太地區-市場規模與預測(2019年-2024年)
• 其他地區-市場規模與預測(2019年-2024年)
• 主要國家
• 地區的市場機會
• 成長要素-需求
• 成長要素-外部要素
• 市場課題
• 市場趨勢

業者情勢

• 業者情勢
• 創造性破壞狀況

供應商分析

• 交易廠商
• 供應商的市場定位
• Baxter International Inc.
• Recipharm AB
• Fresenius SE & Co. KGaA
• Medtronic Plc
• Mylan NV
• Nipro Corp.
• Novartis AG
• SCHOTT AG
• Terumo Corp.

附錄

Technavio has been monitoring the pre-filled syringes market and it is poised to grow by $ 4.23 bn during 2020-2024 progressing at a CAGR of 13% during the forecast period. Our reports on pre-filled syringes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing adoption by pharmaceutical companies and favorable regulations and guidelines. In addition, increasing adoption by pharmaceutical companies is anticipated to boost the growth of the market as well.

The pre-filled syringes market analysis includes material segment and geographic landscapes

Technavio's ‘pre-filled syringes market ’ is segmented as below:

By Material:

• Glass pre-filled syringes
• Plastic pre-filled syringes

By Geographic Landscape:

• Europe
• North America
• APAC
• ROW

This study identifies the increasing number of biopharmaceuticals as one of the prime reasons driving the pre-filled syringes market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our pre-filled syringes market covers the following areas:

• Pre-filled syringes market sizing
• Pre-filled syringes market forecast
• Pre-filled syringes market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pre-filled syringes market vendors that include Baxter International Inc., Becton, Dickinson and Co., Recipharm AB, Fresenius SE & Co. KGaA, Medtronic Plc, Mylan NV, Nipro Corp., Novartis AG, SCHOTT AG, and Terumo Corp. Also, the pre-filled syringes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

• Market Overview

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

• Five forces summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Material

• Market segments
• Comparison by Material
• Glass pre-filled syringes - Market size and forecast 2019-2024
• Plastic pre-filled syringes - Market size and forecast 2019-2024
• Market opportunity by Material

Market Segmentation by Application

• Insulin pre-filled syringes
• Vaccine pre-filled syringes
• Anticoagulant pre-filled syringes
• Others

Market Segmentation by End-user

• Hospitals and clinics
• Home healthcare

Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• Europe - Market size and forecast 2019-2024
• North America - Market size and forecast 2019-2024
• APAC - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography
• Volume drivers - Demand led growth
• Volume driver - External factors
• Market challenges
• Market trends

Vendor Landscape

• Vendor landscape
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Baxter International Inc.
• Recipharm AB
• Fresenius SE & Co. KGaA
• Medtronic Plc
• Mylan NV
• Nipro Corp.
• Novartis AG
• SCHOTT AG
• Terumo Corp.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

Exhibit

• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2019 - 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 - 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2019
• 21: Glass pre-filled syringes - Market size and forecast 2019-2024 ($ million)
• 22: Glass pre-filled syringes - Year-over-year growth 2019-2024 (%)
• 23: Plastic pre-filled syringes - Market size and forecast 2019-2024 ($ million)
• 24: Plastic pre-filled syringes - Year-over-year growth 2019-2024 (%)
• 25: Customer landscape
• 26: Impact of drivers and challenges
• 27: Vendor landscape
• 28: Landscape disruption
• 29: Industry risks
• 30: Vendors covered
• 31: Market positioning of vendors
• 32: Baxter International Inc. - Overview
• 33: Baxter International Inc. - Business segments
• 34: Baxter International Inc. - Key offerings
• 35: Baxter International Inc. - Key customers
• 36: Baxter International Inc. - Segment focus
• 37: Becton, Dickinson and Co. - Overview
• 38: Becton, Dickinson and Co. - Business segments
• 39: Becton, Dickinson and Co. - Key offerings
• 40: Becton, Dickinson and Co. - Key customers
• 41: Becton, Dickinson and Co. - Segment focus
• 42: Recipharm AB - Overview
• 43: Recipharm AB - Business segments
• 44: Recipharm AB - Key offerings
• 45: Recipharm AB - Key customers
• 46: Recipharm AB - Segment focus
• 47: Fresenius SE & Co. KGaA - Overview
• 48: Fresenius SE & Co. KGaA - Business segments
• 49: Fresenius SE & Co. KGaA - Key offerings
• 50: Fresenius SE & Co. KGaA - Key customers
• 51: Fresenius SE & Co. KGaA - Segment focus
• 52: Medtronic Plc - Overview
• 53: Medtronic Plc - Business segments
• 54: Medtronic Plc - Key offerings
• 55: Medtronic Plc - Key customers
• 56: Medtronic Plc - Segment focus
• 57: Mylan NV - Overview
• 58: Mylan NV - Business segments
• 59: Mylan NV - Key offerings
• 60: Mylan NV - Key customers
• 61: Mylan NV - Segment focus
• 62: Nipro Corp. - Overview
• 63: Nipro Corp. - Business segments
• 64: Nipro Corp. - Key offerings
• 65: Nipro Corp. - Key customers
• 66: Nipro Corp. - Segment focus
• 67: Novartis AG - Overview
• 68: Novartis AG - Business segments
• 69: Novartis AG - Key offerings
• 70: Novartis AG - Key customers
• 71: Novartis AG - Segment focus
• 72: SCHOTT AG - Overview
• 73: SCHOTT AG - Business segments
• 74: SCHOTT AG - Key offerings
• 75: SCHOTT AG - Key customers
• 76: SCHOTT AG - Segment focus
• 77: Terumo Corp. - Overview
• 78: Terumo Corp. - Business segments
• 79: Terumo Corp. - Key offerings
• 80: Terumo Corp. - Key customers
• 81: Terumo Corp. - Segment focus
• 82: Currency conversion rates for US$
• 83: Research Methodology
• 84: Validation techniques employed for market sizing
• 85: Information sources
• 86: List of abbreviations